|Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications|
S Rani, AE Ryan, MD Griffin, T Ritter
Molecular Therapy 23 (5), 812-823, 2015
|Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat|
GF Curley, M Hayes, B Ansari, G Shaw, A Ryan, F Barry, T O'Brien, ...
Thorax 67 (6), 496-501, 2012
|Anti‐donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?|
MD Griffin, AE Ryan, S Alagesan, P Lohan, O Treacy, T Ritter
Immunology and cell biology 91 (1), 40-51, 2013
|Addressing the “Fas counterattack” controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo|
AE Ryan, F Shanahan, J O'Connell, AM Houston
Cancer research 65 (21), 9817-9823, 2005
|Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury|
GF Curley, B Ansari, M Hayes, J Devaney, C Masterson, A Ryan, F Barry, ...
Anesthesiology: The Journal of the American Society of Anesthesiologists 118 …, 2013
|Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation.|
AE Ryan, P Lohan, L O'Flynn, O Treacy, X Chen, C Coleman, G Shaw, ...
Molecular Therapy 22 (3), 655-667, 2014
|Autophagosomal IκBα degradation plays a role in the long term control of tumor necrosis factor-α-induced nuclear factor-κB (NF-κB) activity|
A Colleran, A Ryan, A O'Gorman, C Mureau, C Liptrot, P Dockery, ...
Journal of Biological Chemistry 286 (26), 22886-22893, 2011
|Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?|
P Lohan, CM Coleman, JM Murphy, DM Griffin, T Ritter, AE Ryan
Stem Cell Research and Therapy 5 (99), 2014
|Fas ligand promotes tumor immune evasion of colon cancer in vivo|
AE Ryan, F Shanahan, J O’Connell, AM Houston
Cell cycle 5 (3), 246-249, 2006
|Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity|
L O'Leary, AM van der Sloot, CR Reis, S Deegan, AE Ryan, SPS Dhami, ...
Oncogene 35 (10), 1261-1270, 2016
|Mesenchymal stem cell therapy promotes corneal allograft survival in rats by local and systemic immunomodulation|
O Treacy, L O'Flynn, AE Ryan, M Morcos, P Lohan, S Schu, M Wilk, ...
American Journal of Transplantation 14 (9), 2023-2036, 2014
|Anti-donor immune responses elicited by allogeneic mesenchymal stem cells and their extracellular vesicles: are we still learning?|
P Lohan, O Treacy, MD Griffin, T Ritter, AE Ryan
Frontiers in immunology 8, 1626, 2017
|Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis|
AE Ryan, A Colleran, A O'gorman, L O'flynn, J Pindjacova, P Lohan, ...
Oncogene 34 (12), 1563-1574, 2015
|Adenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation|
O Treacy, AE Ryan, T Heinzl, L O'Flynn, M Cregg, M Wilk, F Odoardi, ...
PLoS One 7 (8), 2012
|Immune modulation to improve tissue engineering outcomes for cartilage repair in the osteoarthritic joint|
N Fahy, E Farrell, T Ritter, AE Ryan, JM Murphy
Tissue Engineering Part B: Reviews 21 (1), 55-66, 2015
|Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways|
P Garrido, A Shalaby, EM Walsh, N Keane, M Webber, MM Keane, ...
Oncotarget 8 (46), 80568, 2017
|Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?|
G O'Malley, M Heijltjes, AM Houston, S Rani, T Ritter, LJ Egan, AE Ryan
Oncotarget 7 (37), 60752, 2016
|Pullulan: a new cytoadhesive for cell-mediated cartilage repair|
SE Bulman, CM Coleman, JM Murphy, N Medcalf, AE Ryan, F Barry
Stem cell research & therapy 6 (1), 34, 2015
|Induction of apoptosis in renal cell carcinoma by reactive oxygen species: involvement of extracellular signal-regulated kinase 1/2, p38δ/γ, cyclooxygenase-2 down-regulation …|
M Ambrose, A Ryan, GC O'Sullivan, C Dunne, OP Barry
Molecular pharmacology 69 (6), 1879-1890, 2006
|Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer|
D Basudhar, SA Glynn, M Greer, V Somasundaram, JH No, DA Scheiblin, ...
Proceedings of the National Academy of Sciences 114 (49), 13030-13035, 2017